The Challenge of the Metabolic Syndrome

M. Hanefeld; A. Ceriello; P. E. H. Schwarz; S. R. Bornstein

doi:10.1055/s-2007-985869

Hormone and Metabolic Research, Table of Contents

Horm Metab Res 2007; 39(9): 625-626
DOI: 10.1055/s-2007-985869

Editorial

The Challenge of the Metabolic Syndrome

M. Hanefeld¹ , A. Ceriello² , P. E. H. Schwarz³ , S. R. Bornstein⁴

¹Director, GWT-TUD GmbH, Centre for Clinical Studies - Metabolism and Endocrinology, Dresden
²Warwick Medical School, Clinical Science Research Institute, Clinical Science Building, University Hospital - Walsgrave Campus, UK
³Medical Faculty Carl Gustav Carus at the Technical University of Dresden, Department of Medicine III, Genetics and Prevention of Diabetes, Dresden, Germany
⁴Director and Chair, Endocrinology, Diabetes and Metabolism, Department of Medicine, Carl Gustav Carus, University of Dresden, Dresden, Germany

Abstract

Full Text

References

1 Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001; 414 ((6865)) 782-787
2 Hanefeld M, Ceriello A, Schwarz PE, Bornstein SR. The metabolic syndrome - a postprandial disease?. Horm Metab Res. 2006; 38 ((7)) 435-436
3 Bornstein SR, Wong ML, Licinio J. 150 years of Sigmund Freud: What would Freud have said about the obesity epidemic?. Mol Psychiatry. 2006; 11 ((12)) 1070-1072
4 Zimmet P. The burden of type 2 diabetes: are we doing enough?. Diabetes Metab. 2003; 29 ((4 Pt 2)) 6S9-6S18
5 Schwarz PE, Schwarz J, Bornstein SR, Schulze J. Diabetes prevention -from physiology to implementation. Horm Metab Res. 2006; 38 ((7)) 460-464
6 Schwarz PE, Bornstein SR. Pre-diabetes and metabolic syndrome in Germans. Horm Metab Res. 2006; 38 ((5)) 359
7 Rudofsky Jr G, Reismann P, Schiekofer S, Petrov D, Eynatten M, Humpert PM. et al . Reduction of postprandial hyperglycemia in patients with type 2 diabetes reduces NF-kappaB activation in PBMCs. Horm Metab Res. 2004; 36 ((9)) 630-638
8 Kamari Y, Grossman E, Oron-Herman M, Peleg E, Shabtay Z, Shamiss A. et al . Metabolic stress with a high carbohydrate diet increases adiponectin levels. Horm Metab Res. 2007; 39 ((5)) 384-388
9 Kyrou I, Tsigos C. Stress mechanisms and metabolic complications. Horm Metab Res. 2007; 39 ((6)) 430-438
10 Korenblum W, Barthel A, Licinio J, Wong ML, Wolf OT, Kirschbaum C. et al . Elevated cortisol levels and increased rates of diabetes and mood symptoms in Soviet Union-born Jewish immigrants to Germany. Mol Psychiatry. 2005; 10 ((11)) 974-975
11 Reichel A, Schwarz J, Schulze J, Licinio J, Wong ML, Bornstein SR. Depression and anxiety symptoms in diabetic patients on continuous subcutaneous insulin infusion (CSII). Mol Psychiatry. 2005; 10 ((11)) 975-976
12 Bornstein SR, Schuppenies A, Wong ML, Licinio J. Approaching the shared biology of obesity and depression: the stress axis as the locus of gene-environment interactions. Mol Psychiatry. 2006; 11 ((10)) 892-902
13 Schuppenies A, Schwarz P, Bornstein SR. Seasonal Affective Disorder and HPA Axis Disturbance. Horm Metab Res. 2006; 38 ((6)) 434
14 Ohmura E, Hosaka D, Yazawa M, Tsuchida A, Tokunaga M, Ishida H. et al . Association of free fatty acids (FFA) and tumor necrosis factor-alpha (TNF-alpha) and insulin-resistant metabolic disorder. Horm Metab Res. 2007; 39 ((3)) 212-217
15 Alberti KG, Zimmet P, Shaw J. International Diabetes Federation: a consensus on Type 2 diabetes prevention. Diabet Med. 2007; 24 ((5)) 451-463
16 Hanefeld M, Schaper F. Prandial hyperglycemia: is it important to track and treat? . CurrDiab.Rep.. 2005 Oct; (5(5)) 333-339
17 Schmitz G, Langmann T. Metabolic learning in the intestine: adaptation to nutrition and luminal factors. Horm Metab Res. 2006; 38 ((7)) 452-454
18 Schram MT, Stehouwer CD. Endothelial dysfunction, cellular adhesion molecules and the metabolic syndrome. Horm Metab Res. 2005; 37 ((Suppl 1)) 49-55
19 Kanauchi M, Kawano T, Kanauchi K, Saito Y. New “pre-diabetes” category and the metabolic syndrome in Japanese. Horm Metab Res. 2005; 37 ((10)) 622-626
20 Barthel A, Herzig S, Muller HW, Harborth J, Bornstein SR. RNA interference-based strategies for metabolic syndrome treatment. Horm Metab Res. 2005; 37 ((2)) 59-62
21 Ansurudeen I, Kopprasch S, Ehrhart-Bornstein M, Willenberg HS, Krug AW, Funk RH. et al . Vascular-adrenal niche - endothelial cell-mediated sensitization of human adrenocortical cells to angiotensin II. Horm Metab Res. 2006; 38 ((7)) 476-480
22 Slama G, Elgrably F, Kabir M, Rizkalla SW. Role of low-glycemic-index foods in improving overall glycemic control in type 1 and type 2 diabetic patients and correcting excessive postprandial hyperglycemia. Horm Metab Res. 2006; 38 ((7)) 465-468
23 Pistrosch F, Koehler C, Wildbrett J, Hanefeld M. Relationship between diurnal glucose levels and HbA1c in type 2 diabetes. Horm Metab Res. 2006; 38 ((7)) 455-459
24 Lamounier-Zepter V, Ehrhart-Bornstein M, Bornstein SR. Metabolic syndrome and the endocrine stress system. Horm Metab Res. 2006; 38 ((7)) 437-441
25 Wenying Y, Zhaojun Y. Obesity and hypertension as two anthropometric predictors for metabolic syndrome. Horm Metab Res. 2006; 38 ((7)) 469-470
26 Schwarz PE, Schwarz J, Schuppenies A, Bornstein SR, Schulze J. Development of a diabetes prevention management program for clinical practice. Public Health Rep. 2007; 122 ((2)) 258-263
27 Schwarz PE, Govindarajalu S, Towers W, Schwanebeck U, Fischer S, Vasseur F. et al . Haplotypes in the Promoter Region of the ADIPOQ Gene are Associated with Increased Diabetes Risk in a German Caucasian Population. Horm Metab Res. 2006; 38 ((7)) 447-451
28 Rudofsky Jr G, Schrodter A, Voron’ko OE, Schlotterer A, Humpert PM, Tafel J. et al . Promoter polymorphisms of UCP1, UCP2, and UCP3 are not associated with diabetic microvascular complications in type 2 diabetes. Horm Metab Res. 2007; 39 ((4)) 306-309

Correspondence

Dr. med. P. E.H. Schwarz

Department of Medicine III

Carl Gustav Carus Medical School

Dresden University of Technology

Fetscherstrasse 74

01307 Dresden

Germany

Phone: +49/351/458 27 15

Fax: +49/351/458 73 19

Email: peter.schwarz@uniklinikum-dresden.de